PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR
PROVISION Study, Prospective Randomized Trial Evaluating Clinical Outcomes of FFRangio Versus FFR…
Writer Relocations Alerts Its Customers on Fraudulent Companies Misusing Its Brand Name
MUMBAI, India, May 20, 2025 /PRNewswire/ -- Writer Relocations, a global leader in…
Best Male Enhancement Pills & Libido Booster For Men: (Penis Enlargement Pills) Over The Counter Best ED Pills Non Prescription By Performer 8
Atlantic City, New Jersey, April 27, 2025 (GLOBE NEWSWIRE) -- Best Male…
The Ensign Group Purchases Two Facilities in Washington
April 02, 2025 06:00 ET | Source: The Ensign Group, Inc. SAN…
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
Multi-center clinical trial includes sites located in the US, UK and EU…
German parliament approves the 3rd option of the OCCAR night vision contract under which 25 000 binoculars will be provided equipped with Photonis image intensifier tubes
GERMAN PARLIAMENT APPROVES THE 3rd OPTION OF THE OCCAR NIGHT VISION CONTRACT…
Writer Relocations Alerts Customers About Counterfeit Moving Companies
MUMBAI, India, Dec. 11, 2024 /PRNewswire/ -- Writer Relocations, a pioneer in…
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation…
Stop Bullying – Prevent Suicides – petition the government campaign
Monday 30 September, 2024 Anti-Bullying Campaign 2024 Maybe its time for a…
